Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐vascular Endothelial Growth Factor (VEGF) Drugs for Treatment of Retinopathy of Prematurity." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440238/all/Intermittent_prophylactic_antibiotics_for_bronchiectasis_New. Accessed 18 April 2024.
Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440238/all/Intermittent_prophylactic_antibiotics_for_bronchiectasis_New. Accessed April 18, 2024.
Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/440238/all/Intermittent_prophylactic_antibiotics_for_bronchiectasis_New
Anti‐vascular Endothelial Growth Factor (VEGF) Drugs for Treatment of Retinopathy of Prematurity [Internet]. In: Cochrane Abstracts. [cited 2024 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440238/all/Intermittent_prophylactic_antibiotics_for_bronchiectasis_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
ID - 440238
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440238/all/Intermittent_prophylactic_antibiotics_for_bronchiectasis_New
DB - Evidence Central
DP - Unbound Medicine
ER -